Plan Sponsor Contribution Limits

Plan Sponsor Contribution Limits refer to the maximum amount that an employer can contribute to their employees' 401(k) retirement plans. These limits are set by the Internal Revenue Service (IRS) and serve as guidelines to ensure fairness and adherence to tax regulations within the context of employer-sponsored retirement plans.

Examples:

  • Annual Matching Contributions: One common form of employer contribution is a matching contribution. For instance, a company may match an employee's 401(k) contributions up to a certain percentage of their salary, such as 50% of the first 6% of the employee's salary contributed to the plan. If the IRS sets a Plan Sponsor Contribution Limit of $10,000, the employer can't contribute more than this amount as a match for any individual employee in a given year.
  • Profit-Sharing Contributions: Some employers offer profit-sharing contributions to their employees' 401(k) plans based on the company's financial performance. If the company decides to contribute a fixed percentage of its profits to employees' retirement accounts, the Plan Sponsor Contribution Limits dictate the maximum amount the employer can contribute per employee.
  • Non-Discrimination Testing Compliance: To ensure that 401(k) plans are not unfairly favoring highly compensated employees, the IRS imposes non-discrimination testing requirements. These tests assess the proportion of contributions made by highly compensated employees relative to lower-paid staff. If the employer exceeds the Plan Sponsor Contribution Limits, they risk failing the non-discrimination tests, leading to potential tax implications and corrective measures. Hence, adhering to these limits is crucial for maintaining compliance with IRS regulations.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.